HEPA

Hepion Pharmaceuticals

Delisted

HEPA was delisted on the 12th of May, 2025.

6 hedge funds and large institutions have $15.3M invested in Hepion Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$2.02M
2 +$1.01M
3 +$1.01M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.01M

Top Sellers

1 -$1.01M
2 -$15K
3 -$1K
4
JFA
JNBA Financial Advisors
Minnesota
-$1K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$4.41M
2
$3.4M
3
$2.23M
4
$1.82M
5
$1.26M
6
$416K
7
$333K
8
$240K
9
$236K
10
$188K
11
$158K
12
$145K
13
$117K
14
$109K
15
$72K
16
$26K
17
$23K
18
$23K
19
$22K
20
$20K
21
$19K
22
$18K
23
$13K
24
$12K
25
$8K